Mirati Therapeutics (MRTX) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-3.55
-3.38
-3.21
-3.04

Details

Expected EPS
-3.23
Actual EPS
-3.04
Surprise EPS
0.19
Surprise Percent
+5.88%

Description

Mirati Therapeutics (MRTX) has reported earnings of -3.04 per share for Q2 2023.

0 Comments

Share your thoughts